This fusion is responsible for approximately 50% of cases of infant acute lymphoblastic leukemia (ALL) with MLL1 rearrangement and more than 75% of adult MLL-r ALLs (29). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.